FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors
Fetal hemoglobin (HbF) improves the clinical severity of sickle cell disease (SCD), therefore, research to identify HbF-inducing agents for treatment purposes is desirable. The focus of our study is to investigate the ability of FK228 analogues to induce HbF using a novel KU812 dual-luciferase repor...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Anemia |
Online Access: | http://dx.doi.org/10.1155/2012/428137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|